Rheumatologie: Rituximab Bei ANCA-assoziierten Vaskulitiden

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
doi 10.4414/smf.2013.01415
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EMH Swiss Medical Publishers, Ltd.

Related search

Update Therapie Der ANCA-assoziierten Vaskulitiden

Aktuelle Rheumatologie
Rheumatology
2019English

S1-Leitlinie Diagnostik Und Therapie Der ANCA-assoziierten Vaskulitiden

Zeitschrift fur Rheumatologie
Rheumatology
2017English

Sinunasale Symptome ANCA-assoziierter Vaskulitiden Und Deren Therapie Mit Liposomen

Laryngo- Rhino- Otologie
Otorhinolaryngology
2014English

Orthopädische Rheumatologie

Zeitschrift fur Rheumatologie
Rheumatology
2014English

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Kidney International Reports
Nephrology
2018English

Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

AB0597 Low-Dose Rituximab as Induction Therapy for Japanese Patients With Anca-Associated Vasculitis

2017English

Bildgebung in Der Rheumatologie

Zeitschrift fur Rheumatologie
Rheumatology
2017English

Concurrent Diffuse Alveolar Haemorrhage and Venous Thromboembolism in P-Anca Associated Vasculitis Treated With Rituximab

BMJ Case Reports
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy